Retraction
Reduction of Nuclear Y654-p-β-Catenin Expression Through SH3GL2-Meditated Downregulation of EGFR in Chemotolerance TNBC: Clinical and Prognostic Importance
Paper Information
Record ID:
58881
Author(s):
Journal:
Publication Date:
January 20, 2020
Retraction Date:
November 20, 2024
(<1 year years ago)
Subjects:
Institutions:
- Department of Oncogene Regulation, Chittaranjan National Cancer Institute, Kolkata, West Bengal, India
- Department of Pathology, Nil Ratan Sircar Medical College and Hospital, Kolkata, West Bengal, India
- Department of Surgical Oncology, Chittaranjan National Cancer Institute, Kolkata, West Bengal, India
- Molecular Biology and Basic Research Division, Saroj Gupta Cancer Centre and Research Institute, Kolkata, West Bengal, India
Country:
🇮🇳 IndiaArticle Type:
Publisher:
Wiley
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
Nature of Retraction:
Retraction
Retraction Notice:
10.1002/jcp.31485Additional Notes:
see also: https://pubpeer.com/publications/715B98E22E3ABD5B4604354C8D8B2E
Citations (10)
10
Total Citations2
Post-Retraction(20.0%)
7
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
2
Within 1 year
0
After 2+ years
118
Days since retraction (latest)
Heavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Reduction of Nuclear Y654-p-β-Catenin Expression T...
Unknown Authors
Unknown Journal
Published: Mar 2025
118 days after retraction
Retraction Note: Downregulation of beta-catenin in chemo-tolerant TNBC through changes in receptor and antagonist profiles of the WNT pathway: Clinical and prognostic implications
S. M. Ashiqul Islam, Hemantika Dasgupta, Mukta Basu et al. (7 authors)
Cellular Oncology
Published: Jan 2025
62 days after retraction
SH3GL2 and MMP17 as lung adenocarcinoma biomarkers: a machine-learning based approach
Zengjian Tian, Shilong Yu, Ruizhi Cai et al. (6 authors)
Biochemistry and Biophysics Reports
Open Access
Published: Mar 2024
1 citation
1 citation
240 days before retraction
The Mechanism of DNA Methylation and miRNA in Breast Cancer
Lingyuan Ma, Chenyu Li, Hanlin Yin et al. (11 authors)
International Journal of Molecular Sciences
Open Access
Published: May 2023
44 citations
44 citations
543 days before retraction
Association of Augmented Immune-Staining of G-Quadruplex Tertiary DNA Structure in Chemo-Tolerant TNBC with Downregulation of WNT/Epidermal Growth Factor Receptor Pathway Receptor Genes
S. M. Ashiqul Islam, Mukta Basu, Anup Roy et al. (5 authors)
Journal of Radiation and Cancer Research
Open Access
Published: Jan 2023
689 days before retraction
Targeting regulated cell death (RCD) with small-molecule compounds in triple-negative breast cancer: a revisited perspective from molecular mechanisms to targeted therapies
Minru Liao, Rui Qin, Wei Huang et al. (7 authors)
Journal of Hematology & Oncology
Open Access
Published: Apr 2022
99 citations
99 citations
953 days before retraction
Differential promoter usages of PTCH1 and down regulation of HHIP are associated with HNSCC progression
Balarko Chakraborty, Mukta Basu, Debalina Mukhopadhyay et al. (7 authors)
Pathology - Research and Practice
Published: Mar 2022
9 citations
9 citations
991 days before retraction
High nuclear expression of HIF1α, synergizing with inactivation of LIMD1 and VHL, portray worst prognosis among the bladder cancer patients: association with arsenic prevalence
Mukta Basu, Amvrin Chatterjee, Balarko Chakraborty et al. (11 authors)
Journal of Cancer Research and Clinical Oncology
Published: Jun 2021
7 citations
7 citations
1267 days before retraction
The metronomic combination of paclitaxel with cholinergic agonists inhibits triple negative breast tumor progression. Participation of M2 receptor subtype
Alejandro Español, Agustina Salem, María Di Bari et al. (7 authors)
PLoS ONE
Open Access
Published: Sep 2020
20 citations
20 citations
1532 days before retraction
Quick Stats
Total Citations:
10
Years Since Retraction:
<1 year
Open Access:
Yes
Last Checked:
Jul 24, 2025